Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Biguanides Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The biguanides market has experienced consistent expansion in its size over recent years. It is projected to increase from $5.11 billion in 2025 to $5.28 billion in 2026, registering a compound annual growth rate (CAGR) of 3.4%. Historically, this expansion is linked to factors such as the rising incidence of type 2 diabetes, greater understanding of metabolic conditions, an increase in the availability of generic biguanides, the uptake of oral antidiabetic treatments, and breakthroughs in liver-focused therapies.
The biguanides market size is anticipated to see consistent growth in the coming years, with an expected increase to $5.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 3.1%. This projected growth during the forecast period stems from factors such as the increasing demand for personalized medicine, the expansion of telemedicine services for diabetes care, a rising incidence of pcOS, the development of combination therapies, and government initiatives that promote chronic disease management. Key trends identified for the forecast period include the advent of personalized diabetes management solutions, ongoing combination therapy development, expanded indications extending beyond type 2 diabetes, the adoption of home healthcare and remote patient monitoring, and the availability of cost-effective generic biguanides.
Get A Free Sample Report With In-Depth Market Insights:
Biguanides Market Demand Drivers: What’s Powering Industry Growth?
The biguanides market is anticipated to grow significantly in the future due to the increasing incidence of diabetes. Diabetes is a chronic metabolic disorder defined by elevated blood glucose levels, stemming from either inadequate insulin production or impaired insulin function. This increase in diabetes cases is primarily fueled by shifts in lifestyle, an aging global population, and enhanced diagnostic awareness. The biguanides market contributes to diabetes management through improving insulin sensitivity, decreasing glucose production in the liver, and aiding in the reduction of blood sugar levels for individuals with type 2 diabetes. A relevant example shows that in March 2024, the Office for Health Improvement & Disparities (OHID), a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes it increased by 21%, and the proportion achieving target HbA1c levels reached 37.9%, representing the highest value ever reported. Consequently, the rising prevalence of diabetes is a significant driver for the growth of the biguanides market.
Biguanides Market Segment Outlook: Which Categories Are Growing Fastest?
The biguanides market covered in this report is segmented –
1) By Type: Metformin, Phenformin, Other Types
2) By Dosage Form: Tablets, Oral Solutions
3) By Formulation: Immediate Release, Extended Release
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin
2) By Phenformin: Phenformin Hydrochloride
3) By Other Types: Buformin, Metformin Combinations
Biguanides Market Innovation Trends: What Developments Are Reshaping The Industry?
Entities operating within the biguanide market are prioritizing the development of advanced remedies like extended-release biguanide formulations to enhance patient compliance, optimize glycemic control, and mitigate gastrointestinal side effects. Extended-release biguanide formulations are pharmaceutical products engineered to release their active component gradually over time, thereby maintaining stable blood concentrations, improving tolerability, and fostering better long-term adherence for individuals managing diabetes. For example, in August 2023, Dr. Reddy’s Laboratories, an India-based biotechnology company, launched saxagliptin and metformin hydrochloride extended-release tablets. This USFDA-approved generic version of KOMBIGLYZE XR integrates saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide, providing adults with type 2 diabetes mellitus an effective once-daily treatment option that supports improved glycemic control when used in conjunction with diet and exercise, while also enhancing adherence through its extended-release design.
Biguanides Market Leading Companies And Competitive Benchmarking
Major companies operating in the biguanides market are Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy’s Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories
View The Full Biguanides Market Report:
Biguanides Market Largest Region By Revenue And Market Share
Asia-Pacific was the largest region in the biguanides market in 2025. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
